Program

• Sun, May 2
• Mon, May 3
• Tue, May 4
• Wed, May 5

Tuesday, May 4, 2021

• 09:30 18:15

  North American Viral Hepatitis Elimination Summit

• 09:30 10:00

  VISIT THE VIRTUAL Exhibition

• 10:00 11:00

  Concurrent Sessions

  CLM Symposium 1 – Basic Science and Translational Research - Novel Approaches to Targeting Chronic Liver Disease and Liver Injury
  Moderator: Chris Rose
  
  10:00 - 10:15 | Clinical Evidence on Targeting the Gut Microbiome in Chronic Liver Disease | Johane Allard
  
  10:15 - 10:30 | Inflammatory Mediators, Including Gut Microbiota and TLR on Wound Healing in Fibrogenesis and Carcinogenesis | Robert Schwabe 
  
  10:30 - 10:45 | Single Domain Nanobodies Targeting Viral Infection | Trushar Patel
  
  10:45 - 11:00 | Discussion
  
  CLM Symposium 2 – Special Topics in Hepatology
  Moderator: Kelly Burak
  
  10:00 - 10:15 | Approaches to Complications in PSC Management | Angela Cheung
  
  10:15 - 10:30 | HCC Management in 2021 (Include Post-Transplant Surveillance for HCC) | Alex Aspinall
  
  10:30 - 10:45 | Acute-On – Chronic Liver Failure in the Era of COVID-19 | Constantine Karvellas
  
  10:45 - 11:00 | Discussion

• 11:00 11:50

  How COVID has Impacted Viral Hepatitis and the Elimination Agenda

  This session was co-developed with Gilead and was planned to achieve scientific integrity, objectivity and balance.
  

  Moderator: John Ward
  
  11:00 - 11:20 | Effects of COVID-19 on the Cascade of Care | Naveed Janjua
  
  11:20 - 11:40 | Lessons Learned from COVID that Could Enhance Viral Hepatitis Elimination | Betsy Verna
  
  11:40 - 11:50 | Q&A

• 11:00 11:30

  HDV Cure

  Moderator: Scott Fung
  
  11:00 - 11:20 | HDV Cure: How close are we and what tools do we need? | Jeffrey Glenn
  
  11:20 - 11:30 | Discussion

• 11:30 12:30

  Strategies for HBV Cure

  Moderator: Timothy Block
  
  11:30 - 11:50 | The Antiviral Approach | Anna Lok
  
  11:50 - 12:10 | The Immunological Approach | Barbara Rehermann
  
  12:10 - 12:30 | Panel Discussion

• 11:50 13:00

  Opportunities from COVID to Enhance Elimination

  Moderator: Jordan Feld
  
  11:50 - 12:10 | Leveraging COVID Testing to Enhance HBV and HCV Screening: Opportunities for Progress Toward Elimination | Mel Krajden
  
  12:10 - 12:30 | COVID-19 in Patients with Liver Disease and Management of Viral Hepatitis in the COVID Era | Oren Fix
  
  12:30 - 13:00 | Panel Discussion Focused on Catch-up from COVID to Get Back on Track | Norah Terrault

• 12:30 13:00

  HCC After Cure of HCV or Suppression of HBV

  Emmanuel Thomas

• 13:00 13:30

  Break | VIRTUAL EXHIBIT BOOTHS VISIT

• 13:30 14:30

  Oral Presentations

  Panel 2

• 13:30 14:30

  CAHN Session

  Nurse-Led Models of Care
  Moderator: TBD
  
  13:30 - 13:50 | CV Micro Elimination at the Calgary Drop In Center: an interdisciplinary approach to screening and treatment | Kate Newcombe
  
  13:50 - 14:10 | Culturally Relevant Perspectives Informing Indigenous Liver Health Awareness | Kate Dunn
  
  14:10 - 14:30 | Cirrhosis Care Alberta - a QI project | Michelle Carbonneau

• 14:30 15:30

  CAHN Session

  Case Studies In Liver Disease
  Moderator: Elizabeth Lee
  
  14:30 - 14:45 | HCV treatment dilemma | Liza Abraham
  
  14:45 - 15:00 | Title TBD | Jacqui Pinto
  
  15:00 - 15:15 | Challenges faced by the Queer Community in accessing health care | Nikki Kelly
  
  15:15 - 15:30 | HCV reinfection | Pam Ford

• 14:30 15:00

  CanHepC Awards Ceremony

• 15:00 15:30

  Elimination Summit Closing Remarks

• 15:30 17:00

  CAHN AGM

• 15:30 16:30

  CASL AGM

• 15:30 16:15

  Poster Tours

  Poster Tour 3
  
  Poster Tour 4

• 17:45 18:15

  VISIT THE VIRTUAL Exhibition